Table 3 Comparison of clinical outcome between CTO-R group and CTO-NR group
Event, n (%) | CTO-R group (n = 300) | CTO-NR group (n = 263) | P |
|---|---|---|---|
MACCE | 36 (12) | 58 (22.1) | 0.001 |
All-cause death | 7 (2.3) | 17 (6.5) | 0.016 |
Cardiac death | 4 (1.3) | 16 (6.1) | 0.002 |
Re-hospitalization | 34 (11.3) | 46 (17.5) | 0.037 |
Heart failure | 8 (2.7) | 4 (1.5) | 0.348 |
Target vessel revascularization | 1 (0.3) | 6 (2.3) | 0.037 |
Recurrent myocardial infarction | 6 (2) | 5 (1.9) | 0.933 |
Stroke | 1 (0.3) | 3 (1.1) | 0.255 |